Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Identification of clinically relevant biomarkers of epileptogenesis — a strategic roadmap
Michele Simonato, Denes V. Agoston, Amy R. Brooks‐Kayal, et al.
Nature Reviews Neurology (2021) Vol. 17, Iss. 4, pp. 231-242
Closed Access | Times Cited: 79

Showing 1-25 of 79 citing articles:

Neuroinflammatory mediators in acquired epilepsy: an update
Yu Chen, Marwa M. Nagib, Nelufar Yasmen, et al.
Inflammation Research (2023) Vol. 72, Iss. 4, pp. 683-701
Open Access | Times Cited: 59
New epilepsy therapies in development
Pavel Klein, Rafal M. Kaminski, Matthias J. Koepp, et al.
Nature Reviews Drug Discovery (2024) Vol. 23, Iss. 9, pp. 682-708
Closed Access | Times Cited: 28
The pharmacological treatment of epilepsy: recent advances and future perspectives
Emilio Perucca
Acta Epileptologica (2021) Vol. 3, Iss. 1
Open Access | Times Cited: 62
Post-Traumatic Epilepsy and Comorbidities: Advanced Models, Molecular Mechanisms, Biomarkers, and Novel Therapeutic Interventions
Victoria M. Golub, Doodipala Samba Reddy
Pharmacological Reviews (2022) Vol. 74, Iss. 2, pp. 387-438
Open Access | Times Cited: 58
Dogs as a Natural Animal Model of Epilepsy
Wolfgang Löscher
Frontiers in Veterinary Science (2022) Vol. 9
Open Access | Times Cited: 40
Disease-modifying effects of sodium selenate in a model of drug-resistant, temporal lobe epilepsy
Pablo M. Casillas‐Espinosa, Alison Anderson, Anna Harutyunyan, et al.
eLife (2023) Vol. 12
Open Access | Times Cited: 23
Rethinking the initial changes in subarachnoid haemorrhage: Focusing on real-time metabolism during early brain injury
Yujie Chen, Ian Galea, R. Loch Macdonald, et al.
EBioMedicine (2022) Vol. 83, pp. 104223-104223
Open Access | Times Cited: 32
Experimental and Clinical Biomarkers for Progressive Evaluation of Neuropathology and Therapeutic Interventions for Acute and Chronic Neurological Disorders
Doodipala Samba Reddy, Hasara Abeygunaratne
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 19, pp. 11734-11734
Open Access | Times Cited: 31
Prevention of epileptogenesis – are we there yet?
Matthias J. Koepp, Eugen Trinka, Wolfgang Löscher, et al.
Current Opinion in Neurology (2024)
Closed Access | Times Cited: 8
Virus-Induced Epilepsy vs. Epilepsy Patients Acquiring Viral Infection: Unravelling the Complex Relationship for Precision Treatment
Bárbara Costa, Nuno Vale
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 7, pp. 3730-3730
Open Access | Times Cited: 6
New approaches for developing multi-targeted drug combinations for disease modification of complex brain disorders. Does epilepsy prevention become a realistic goal?
Wolfgang Löscher, Pavel Klein
Pharmacology & Therapeutics (2021) Vol. 229, pp. 107934-107934
Open Access | Times Cited: 40
Antiepileptogenesis and disease modification: Progress, challenges, and the path forward—Report of the Preclinical Working Group of the 2018 NINDS‐sponsored antiepileptogenesis and disease modification workshop
Aristea S. Galanopoulou, Wolfgang Löscher, Laura S. Lubbers, et al.
Epilepsia Open (2021) Vol. 6, Iss. 2, pp. 276-296
Open Access | Times Cited: 35
Epilepsy and its neurobehavioral comorbidities: Insights gained from animal models
Wolfgang Löscher, Carl E. Stafstrom
Epilepsia (2022) Vol. 64, Iss. 1, pp. 54-91
Open Access | Times Cited: 28
The Neurovascular Unit Dysfunction in the Molecular Mechanisms of Epileptogenesis and Targeted Therapy
Xiuxiu Liu, Ying Zhang, Yanming Zhao, et al.
Neuroscience Bulletin (2024) Vol. 40, Iss. 5, pp. 621-634
Open Access | Times Cited: 5
Theranostic Applications of Scaffolds in Current Biomedical Research
Sarika J Patil, Vandana M Thorat, Akshada Amit Koparde, et al.
Cureus (2024)
Open Access | Times Cited: 5
Antiepileptogenesis and disease modification: Clinical and regulatory issues
Jacqueline A. French, Martina Bebin, Marc A. Dichter, et al.
Epilepsia Open (2021) Vol. 6, Iss. 3, pp. 483-492
Open Access | Times Cited: 29
The gut microbiota as a biomarker in epilepsy
Emilio Russo
Neurobiology of Disease (2021) Vol. 163, pp. 105598-105598
Open Access | Times Cited: 29
Novel Approaches to Prevent Epileptogenesis After Traumatic Brain Injury
Chris G. Dulla, Asla Pitkänen
Neurotherapeutics (2021) Vol. 18, Iss. 3, pp. 1582-1601
Open Access | Times Cited: 28
Discovery and Validation of Circulating microRNAs as Biomarkers for Epileptogenesis after Experimental Traumatic Brain Injury–The EPITARGET Cohort
Mette Heiskanen, Shalini Das Gupta, James D. Mills, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2823-2823
Open Access | Times Cited: 11
Brain cell-specific origin of circulating microRNA biomarkers in experimental temporal lobe epilepsy
Elizabeth Brindley, Mona Heiland, Catherine Mooney, et al.
Frontiers in Molecular Neuroscience (2023) Vol. 16
Open Access | Times Cited: 11
Autoimmune-associated Epilepsy – a challenging concept
Nico Melzer, Felix Rosenow
Seizure (2024)
Open Access | Times Cited: 4
Clinical trials of prevention of acquired epilepsy: New proof‐of‐concept approach to restart trials
Pavel Klein, Matthias J. Koepp, Alexander Rotenberg, et al.
Epilepsia (2025)
Closed Access
An Interplay Between Post-Traumatic Epilepsy and Associated Cognitive Decline: A Systematic Review
Irma Wati Ngadimon, Ángel Aledo‐Serrano, Alina Arulsamy, et al.
Frontiers in Neurology (2022) Vol. 13
Open Access | Times Cited: 17
Prognostic interictal electroencephalographic biomarkers and models to assess antiseizure medication efficacy for clinical practice: A scoping review
Ashley Reynolds, Michaela Vranic‐Peters, Alan Lai, et al.
Epilepsia (2023) Vol. 64, Iss. 5, pp. 1125-1174
Open Access | Times Cited: 10
Reactive oxygen species in status epilepticus
Matthew C. Walker
Epilepsia Open (2023) Vol. 8, Iss. S1
Open Access | Times Cited: 9
Page 1 - Next Page

Scroll to top